TABLE 2.
KEY CHARACTERISTICS OF THERAPIES FOR MODERATE TO SEVERE DRY EYE SYNDROME*
| QUALITY OF TREATMENT OPTION | N | % RESPONDENTS SELECTING ANSWER |
|---|---|---|
| Ability to provide continuous relief | 197 | 84.2 |
| Patient acceptance | 193 | 82.5 |
| Ability to use long-term | 173 | 73.9 |
| Dosing frequency | 155 | 66.2 |
| Length of time preserving the tear film | 155 | 66.2 |
| Length of time to effectiveness | 148 | 63.2 |
| Preservative-free | 126 | 53.8 |
| Ability to use with contact lenses | 119 | 50.9 |
| Ability for concomitant use with other medications | 102 | 43.6 |
| Other (please specify) | 9 | 3.8 |
*
Based on the survey question: When selecting products for moderate to severe dry eye patients, which of the following are key considerations? (Multiple responses allowed.)